ArticleMolecular therapy oncolytics2019

The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellular Carcinoma.

Brynjar Mauseth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.